Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001950047-25-001137
Filing Date
2025-02-21
Accepted
2025-02-21 16:23:45
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 3313
  Complete submission text file 0001950047-25-001137.txt   4859
Mailing Address C/O MOURANT GOVERNANCE SERVICES (CAYMAN) 94 SOLARIS AVENUE, CAMANA BAY GRAND CAYMAN E9 KY1-1108
Business Address C/O MOURANT GOVERNANCE SERVICES (CAYMAN) 94 SOLARIS AVENUE, CAMANA BAY GRAND CAYMAN E9 KY1-1108 13459494123
BeiGene, Ltd. (Subject) CIK: 0001651308 (see all company filings)

EIN.: 981209416 | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-37686 | Film No.: 25652281
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O MOURANT GOVERNANCE SERVICES (CAYMAN) 94 SOLARIS AVE, CAMANA BAY, PO BOX 1348 GRAND CAYMAN E9 KY1-1108
Business Address
Wang Lai (Reporting) CIK: 0001852291 (see all company filings)

Type: 144